This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on July 22, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Purchase of Imtakt Liquid Chromatography Columns
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The CDC’s National Center for HIV, Viral Hepatitis, STD, and TB Prevention plans to award a sole source purchase order to Herman-Robbins, LLC dba Imtakt USA for the procurement of Imtakt Unison UK-C-18 and Cadenza HS-C18 liquid chromatography columns. These columns are essential consumables used in validated assays that detect and measure antiretroviral drugs in biological specimens, and their specific chemistry is integral to maintaining the accuracy, retention time, resolution, and reproducibility of test results. Substituting any other column would necessitate extensive and impractical revalidation, disrupting critical public health monitoring efforts. Imtakt USA is the only authorized source for these proprietary columns, justifying the sole source acquisition under FAR Part 12.102(a). No competitive solicitation will be posted on sam.gov, and the contract will be issued directly to Imtakt USA unless a responsible source demonstrates it can meet the exact technical requirements. Interested parties may submit a written capability statement to the Contracting Officer by the response deadline of August 6, 2026, to be considered for potential competition, though the decision to open the procurement remains entirely at the discretion of the agency. All submissions must be in writing and sent to Liubov Kriel at vyh1@cdc.gov, referencing solicitation number 2026-Q-99318. The purchase will be executed through the CDC Office of Acquisition Services under the Department of Health and Human Services, with performance based in Atlanta, Georgia. No set-aside provisions apply, and the NAICS code for this procurement is 334516. Verbal inquiries will not be accepted, and no responses will be provided to submissions unless they directly impact the decision to compete the requirement.
General Info
Agency
NAICS
Place of Performance
Atlanta, GA, 30341, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
Organization & Contact Information
Full Description
The Center for Disease Control and Prevention (CDC), National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) intends to award a sole source purchase order to the Herman-Robbins, LLC (dba Imtakt USA), 500 SW 116th Ave, Portland, OR, 97225 for the purchase of Purchase of Imtakt Liquid Chromatography Columns.
The authority for this sole source acquisition is in accordance with FAR Part 12.102(a).
The program requires replacement Imtakt Unison UK-C-18 and Cadenza HS-C18 liquid chromatography columns, which are consumable items depleted through routine use in assays that detect and measure antiretroviral drugs in biological specimens. These assays were developed and validated specifically using these column products, and method validation for the testing is tied directly to the exact column chemistry used during development; substituting a different column could alter retention time, resolution, and reproducibility, requiring costly and time-prohibitive revalidation and risking disruption to ongoing antiretroviral drug monitoring where result accuracy and consistency are critical. Imtakt Unison UK-C-18 and Cadenza HS-C18 columns are proprietary products manufactured by Imtakt Corporation, and Imtakt USA is the sole authorized source through which these exact columns can be procured; therefore, Imtakt USA is the only responsible source capable of supplying the replacement columns needed to maintain the validity and continuity of the program's existing assays.
As a result of this synopsis, no competitive solicitation will be posted on sam.gov. We will issue only one solicitation to the identified entity. However, responsible sources that believe they can meet these requirements are encouraged to identify themselves and give written notice by providing a capability statement to the Contracting Officer by the closing date of this posting. The Contracting Officer will not respond to verbal request. All requests must be in writing.
A determination by the Government not to compete this proposed action will be based on responses to this notice and are solely within the discretion of the Contracting Officer. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement.
Inquiries shall be sent to Liubov Kriel by email at vyh1@cdc.gov and reference solicitation #2026-Q-97212 on the subject line.
More opportunities from Department Of Health And Human Services → CDC Office Of Acquisition Services
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
